From bridging access to ensuring drug safety, public policies play a critical role in supporting research to create lifesaving treatments and cures. Innovative policy solutions ensure that the health care system keeps up with the pace of R&D to continually improve and yield results in the future.
RELATED ARTICLES
The Next Threat: Combatting Antimicrobial Resistance
After decades of helping to lower the mortality rate from pneumonia, tuberculosis and other types of infection, the medicines we rely on now face the growing threat of antimicrobial resistance.
Battling Disease with Cell and Gene Therapy
Cell and gene therapies can often sound like science fiction. But their possibilities represent a new era of medicine.
Fixing Medicare for America’s Seniors
Ensuring timely, affordable access to new medicines for seniors has never been more vital.
Changes to the Health Care System Should Prioritize Patient Affordability
A group of experts recently discussed the ways we can realign the U.S. health care system to improve access and affordability for patients.
3 Groundbreaking Innovations That Were First Approved in the United States
Breakthrough therapies are approved in America quickly, and this translates to hope for patients and families.
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
A New Personalized Cancer Treatment Shows What’s Possible in the New Era of Medicine
In recent years, researchers have expanded the limits of science so quickly that methods of treatment thought to be impossible a decade ago are now a reality.
Change on the Horizon: The Future of Cancer Treatment
Experts and thought leaders touching every aspect of cancer came together for "Future Shapers: A New Era in Cancer Care", a conversation led by Axios and part of PhRMA's GoBoldly Campaign.
Policy Solutions to Push Progress Forward
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
Our Commitment
We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough and dedicated to ending the burdens of disease. And with new, innovative medicines on the horizon, we're closer than ever to reaching our goal.
Recognizing Diversity in Clinical Trials
Every time you take a medicine – even if it's just for a headache – you are benefitting from the results of a clinical trial.
Florida Clinical Trials
Recently, America's biopharmaceutical companies joined the American Cancer Society for the Cancer Action Network Clinical Trials Policy Forum at the Mayo Clinic in Jacksonville, Florida.
Addressing Mental Health Using Online Tools
Identifying early signs of mental health issues online can significantly improve our ability to treat individuals suffering from mental illness in a timely, and in some cases life-saving fashion.
Research Doesn’t End On A Medicine’s Approval
Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better understand a medicine's full value.
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors
Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.
